The sole health system in a small city, in which every doctor is employed by the system, is a much easier system to organize for today’s healthcare redesign than a situation where multiple systems serve a more populated area, says Arthur Vercillo, MD, FACS, a surgeon and regional president of Excellus Blue Cross Blue Shield. Upstate New York is an excellent example of the geographic variation found in much of the country. “Developing a healthcare delivery system in that environment is different,” he concedes, and one size doesn’t fit all. In this area, he says, “We still have mom-and-pop type of doctors,” where the next closest physician is 50 miles away. “Some are still taking notes and doing records by hand, not electronic medical records.” Dr Vercillo’s organization is trying to be an “available collaborative resource,” in an effort to create effective systems of care in which providers of nearly any size can participate, regardless of sophistication.
Dennis Scanlon, PhD, session moderator, comments that “We’re asking these new delivery systems to do a lot,” including population management, care coordination, quality measuring and reporting, in addition to taking on risk. This seems to favor mega-organizations, or at least a big enough organization that has the resources, staff, and health information technology to do all this.
There are many ways to take on financial risk, even for smaller providers, says Francois de Brantes, MS, MBA, executive director, Healthcare Incentives Improvement Institute, and he is seeing innovation in the risk-taking arena. He believes in the dictum that “Form should follow function, and function should follow incentives.” Reinsurers are beginning to understand the big business of possibly starting a reinsurance layer and boundaries for providers that allows them to take on certain financial risks.
An important issue, Mr de Brantes acknowledges, is how and when the patient affected. He believes that the physician should be able to refer the patient to whoever is best, “without locking [the patient] into a single kind of organization.” This also means allowing the 30% to 40% of members who require little more than preventive care to get it where they want, especially if it is being paid out of pocket.
Ateev Mehrotra, MD, MPH, associate professor of health care policy and medicine at Harvard Medical School and a hospitalist at Beth Israel Deaconess Medical Center, also expresses concern for patients because of the consolidation brought on by delivery system reform. He states that coordinated care is important for a certain subset of individuals, but it is not critical for all patients, and that could limit choices. When he deals with large organizations that are considering the ACO route, he feels they may try to discourage patients from going out of the system. Beyond limiting patient choice, another real problem in consolidation, he says, is “when you have a large organization with a lot of market power; we know what happens if they drive up prices.”
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
What We’re Reading: RSV Vaccine Demand; Permanent Contraception; Drug Negotiation Impact
December 8th 2023The Biden administration recently met with manufacturers of respiratory syncytial virus (RSV) immunizations to encourage them to increase access to the vaccine; since the Dobbs v Jackson decision, many patients have been seeking more permanent reproductive health care solutions; a Mathematica analysis showed that Medicare prescription drug price negotiations could have cut seniors’ out-of-pocket costs by nearly a quarter had the program been in effect in 2021.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
New Insights on Breast Cancer Outcomes Among Sexual, Gender Minorities
December 7th 2023Despite there being a great demand for data collection on sexual orientation and gender identity in the cancer space, individuals who identify as a sexual and gender minority remain poorly represented.
Read More
Research Reveals the Role of Structural Racism in Lung Cancer Risk
December 7th 2023Spanning 22 studies, the analysis illuminated housing disparities, occupational hazards, unequal health care access, economic inequality, and discriminatory industry practices and how they collectively contribute to heightened lung cancer risks.
Read More